MiRXES
News,Asia,Singapore,Biotech / MedTech
Singapore’s Mirxes to list in Hong Kong after securing $50M in Series D funding
Mirxes Holding Company Limited, a Singapore-headquartered biotech firm, announced Tuesday that it has filed listing application with The Stock Exchange of Hong Kong Limited after securing $50 million Series D funding.
July 26, 2023
News,Biotech / MedTech,Singapore,Investments
MiRXES secures $77M Series C funding to accelerate multi-cancer early detection pipeline
Led by CR-CP Life Science Fund, this new capital will support MiRXES’s growth as a global leader in cancer early detection tests and preventive healthcare.
July 8, 2021
Singapore’s Sea revenue up 30.8 pct on year in third quarter
November 13, 2024
Singapore’s Sea revenue up 30.8 pct on year in third quarter
November 13, 2024